Prokarium, the biotech startup working on novel immunotherapies and vaccines based on its engineered microbial platform, has raised $21M in Series B funding from investors that include Korea Investment Partners, The Future Fund, Flerie Invest, and Riyadh Valley Company. Founded by Rocky Cranenburgh in 2012, Prokarium has now raised a total of $47.6M in reported equity funding. Check out our exclusive coverage of Prokarium’s funding round .
The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (London Tech, NYC Tech, LA Tech, Paris Tech, Boston Tech) TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the business community and beyond. Find out how to run a digital campaign that will return your investment here.
